Page 408 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 408

386   PART IV    Specific Malignancies in the Small Animal Patient



          TABLE 21.4     Survival Times of Dogs with Surgically
                      Treated Mast Cell Tumors According to
                                     a
  VetBooks.ir  Investigator  Histologic Grade Surgery  Time (weeks)
                       Number  Percent  Months Post  Median Survival
                       of Dogs Alive
            Bostock 59
            Low grade  39     79     7        NR
            Intermediate   30  37    7
              grade
            High grade  45    15     7
            Patnaik 14
            Low grade  30     83     48       NR
            Intermediate   36  44    48
              grade
            High grade  17     6     48
            Bostock 104
            Low grade  19     90     NR       >40 b
            Intermediate   16  75             >36
              grade
            High grade  15    27               13
            Murphy 84
            Low grade   87    100    12       >80 b
            Intermediate   199  92   12       >80
              grade
            High grade  54     46    12        40
            Simoes 85
            Low grade  33     91     20       NR
            Intermediate   35  71    20
              grade
            High grade  19    42     20
                                                               • Fig. 21.3  Subungual undifferentiated mast cell tumor in an English bulldog.
            NR, Not reported.                                  As with some mast cell tumors in this location, early lymph node metastasis
            a Unclear in these studies if death was due to metastasis or local recurrence.  has occurred. (Courtesy D. Vail, University of Wisconsin–Madison.)
            b Medians not reached at the time of last follow-up (i.e., >50% alive).

                                                                  The potential role of KIT dysregulation in MCT prognosis
         of argyrophilic nucleolar organizer regions (AgNOR), another   was investigated by assessing KIT immunohistochemical staining
         surrogate marker of proliferation. These have been correlated   patterns on histopathologic specimens. 108  Three distinct patterns
         with histologic grade and postsurgical outcome. 79,98  Finally, pro-  were identified: membrane, focal/stippled, and diffuse cytoplas-
         liferating cell nuclear antigen (PCNA), another indicator of cell   mic staining. Although there was some evidence that dogs with
         proliferation, has been used to determine the biologic behavior   diffuse cytoplasmic KIT staining patterns did not live as long as
         of MCTs, although this is probably not as reliable as the other   those with other patterns, no group reached an MST and most
         markers. 79,98,99  The previously discussed markers of proliferation   dogs in each of the KIT staining groups evaluated experienced
         all require the use of special stains. In contrast, mitotic index (MI,   extremely long postoperative STs. 108  The presence of c-kit activat-
         number of mitoses per 10 HPF) in hematoxylin and eosin–stained   ing mutations has been associated with a higher rate of local recur-
         sections has been used to assess the biologic behavior of canine   rence, metastasis, and death from disease, suggesting that KIT
         MCTs. In one study, those dogs with tumors possessing an MI <5   dysregulation confers a more aggressive phenotype to MCT. 43,48,49
         had a median ST (MST) of 80 months compared with 3 months   Finally, investigators have attempted to correlate histologic grad-
         for those possessing a MI >5, suggesting that MI is a strong pre-  ing of MCT with a combined Ki67/PCNA/AgNOR/KIT immu-
         dictor of overall survival for dogs with MCTs. 100  Additional stud-  nohistochemical scoring. 109  No significant correlation was found
         ies have also found a role for MI in MCT prognosis. 87,97,101–103  for KIT staining and MCT grade, but high Ki67/PCNA/AgNOR
            Other cellular assessments have been employed to evaluate the   scores all positively correlated with tumor grade (i.e., higher scores
         biologic behavior of MCTs. A study of DNA ploidy determined by   for higher grade). This suggests that proliferation indices increase
         flow cytometric analysis suggested a trend toward shorter survival   with increasing grade and are ultimately reflected in the eventual
         and higher clinical stage of disease in aneuploid tumors compared   biologic behavior of the tumor.
         with diploid tumors. 104  Complementary to this, increases in DNA   Tumor location has been investigated as a potential prognos-
         CNV also appear to be associated with higher grade and shorter   tic indicator. 58,110–114  Tumors in the preputial/inguinal area, sub-
         postsurgical ST. 51,52  Studies have found a correlation between   ungual (nail bed) region (Fig. 21.3), and other mucocutaneous
         intratumor microvessel density and invasiveness, MI, and progno-  sites, including the oral cavity and perineum, historically have
         sis, 89,105  and a correlation between nuclear characteristics (assessed   been associated with aggressive behavior.  Two reports did not
         by computerized morphometry) and outcome and grade. 106,107  show a poorer prognosis for tumors occurring in the inguinal
   403   404   405   406   407   408   409   410   411   412   413